SK 4 K + channels are therapeutic targets for the treatment of cardiac arrhythmias-Reference-Cited by-同舟云学术

SK 4 K + channels are therapeutic targets for the treatment of cardiac arrhythmias

Published:2017-02-20 Issue:4 Volume:9 Page:415-429
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Haron‐Khun Shiraz¹²,Weisbrod David¹,Bueno Hanna¹,Yadin Dor²,Behar Joachim³,Peretz Asher¹,Binah Ofer⁴,Hochhauser Edith⁵,Eldar Michael²,Yaniv Yael³,Arad Michael²^ORCID,Attali Bernard¹^ORCID

Affiliation:

1. Department of Physiology and Pharmacology The Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

2. Leviev Heart Center Sheba Medical Center Tel Hashomer Tel Aviv Israel

3. Laboratory of Bioenergetic and Bioelectric Systems Biomedical Engineering Faculty Technion—Israel Institute of Technology Haifa Israel

4. Department of Physiology Ruth & Bruce Rappaport Faculty of Medicine Technion—Israel Institute of Technology Haifa Israel

5. The Cardiac Research Laboratory of the Department of Cardiothoracic Surgery Felsenstein Medical Research Center Rabin Medical Center Tel Aviv University Petah Tikva Israel

Funder

Israel Science Foundation

Israel Academy of Sciences and Humanities

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201606937

Reference55 articles.

1. Cardiac channelopathies: Genetic and molecular mechanisms

2. A Family with Recurrent Sudden Death and No Clinical Clue